Compare Ascendis Pharma A/S (ASND) vs Reddit Inc (RDDT) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Ascendis Pharma A/S vs Reddit Inc — how do they compare? Ascendis Pharma A/S trades at $270.99 (market cap $17.74B), while Reddit Inc trades at $194.62 (market cap $37.60B). The key difference: Reddit Inc is far larger — about 2.1× Ascendis Pharma A/S's market cap, and Ascendis Pharma A/S is trading nearer its 52-week high, Reddit Inc nearer its low. Which is the better fit depends on your goals.
| ASND | RDDT | |
|---|---|---|
Market Cap | $17.74B | $37.60B |
Sector | Health | Media |
52-Week High | $277.18 | $270.71 |
52-Week Low | $163.32 | $121.84 |
Enterprise Value | $18.11B | $34.86B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Ascendis Pharma (ASND) trades at $270.45, down 1.81% on the day, with a bullish technical outlook supported by moving averages and positive analyst sentiment. The company reported Q1 2026 revenue of $241 million (converted from €197 million for YORVIPATH and €44 million for SKYTROFA, Q1 2026 earnings report May 7, 2026) and beat EPS expectations, while recent news highlights clinical progress in achondroplasia and hypoparathyroidism treatments. Valuation ratios are elevated with a P/E of 31.38 and P/S of 16.94, reflecting growth expectations.
The outlook is positive due to strong revenue growth, multiple product launches, and a 92% analyst buy rating with a $321.17 price target. Key risks include high debt levels, persistent net losses despite improving margins, and reliance on successful commercialization of new therapies. The stock's upside depends on execution of growth strategy and achieving profitability.
Reddit (RDDT) trades at $195.42, down 2.58% amid recent profit-taking but maintains strong fundamentals with 45% revenue growth and expanding profitability. The stock shows bullish technical signals with support at $193 and resistance at $204, while analyst consensus remains strongly positive with a $229.11 price target. Recent news highlights digital advertising momentum and AI safety initiatives as key growth drivers.
Outlook remains favorable with accelerating digital ad spending and strong execution, though elevated valuation metrics and competitive pressures present risks. The upcoming Q2 2026 earnings report on July 30 will be crucial for validating growth trajectory and maintaining investor confidence in the company's expansion story.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ascendis Pharma A/S
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.
Read more on ASND →About Reddit Inc
Reddit Inc. operates a vast network of online communities organized around various interests, known as 'subreddits'. Functioning as a hybrid of a social media platform and a discussion forum, the company generates revenue primarily through advertising and premium subscriptions. Reddit is a major hub for user-generated content, trending news, and viral discussions, and it is a key player in the digital advertising and social media landscape.
Read more on RDDT →
